According to the research report titled ‘GLOBAL HORMONE REPLACEMENT THERAPY MARKET 2021-2028,’ available with MarketStudyReport, global hormone replacement therapy market is slated to expand at 7.75% CAGR during 2021-2028.

Rise in the awareness of health problems associated with menopause, the growing prevalence of hormonal disorders, and new product launches by major giants are factors contributing to the development of global hormone replacement therapy market.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/3855553/

Moreover, availability of alternative therapy, coupled with the launch of telemedicine practice services is creating remunerative prospects for businesses in this domain.

Despite the positive outlook, the huge costs involved in the treatments like high-quality medicines, follow-up appointments, and customized therapy, and adverse risks associated with the therapy are likely to stymie the progress of market in the forthcoming years.

In terms of therapy type, the business sphere is categorized into progestogen hormone replacement therapy, estrogen hormone replacement therapy, testosterone hormone replacement therapy, human growth hormone replacement therapy, and thyroid hormone replacement therapy. 

Based on disease type, worldwide hormone replacement therapy industry is divided into hypothyroidism, menopause, growth hormone deficiency, male hypogonadism, and others. With respect to route of administration, the market is classified into transdermal, oral, parenteral, and others. 

Concerning the geographical terrain, Asia Pacific market is poised to observe a robust growth rate during the assessment timeframe, owing to the advancement in healthcare services specifically related to hormonal imbalance disorders, rising awareness about menopause among the huge population base, and growth in geriatric populace across the region. 

The companies defining the competitive sphere of global hormone replacement therapy industry include Novartis International AG, Abbott Laboratories, Dr. Reddy's Laboratories Ltd., Amgen Inc., Viatris Inc., Genentech Inc., Merck Group, Pfizer Inc., Novo Nordisk A/S, ANI Pharmaceuticals Inc., Noven Pharmaceuticals Inc., Eli Lilly & Company Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., and Ipsen among others.